🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How to use #CRISPR gene editing to fight heart disease, the #1 killer worldwide: A thread 10+ years in the making. This one starts in 2009 when I was a postdoc in Sek Kathiresan MD lab MassGeneral News/Broad Institute studying ❤ risk factors like cholesterol & triglycerides. (thread)

#cardiology #cardiotwitter #heartattack #prevention

Zainali Chunawala JAHA APS is much more common than people think and dramatically underdiagnosed. This is a perfect scenario to check IgG/M/A autoantibodies against beta-2 glycoprotein I, anticardiolipin, lupus anticoagulant. Up to 10% in acute MI. APS Foundation of America

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death tctmd.com/news/acute-mi-… Zainali Chunawala Melissa Caughey PhD John P Erwin III MD MBA MACC (#BigPoppy ) Dr. Deepak L. Bhatt Justin Levisay Mark J Ricciardi MD @NorthShoreWeb

1/ Debate: should we use CAC testing in familial hypercholesterolemia? Raul Santos vs. Don Lloyd-Jones #ASPC2023 Heterozygous FH is associated with high ASCVD risk Statin therapy changes natural history of FH But many pts persist with high LDL-C

1/ High-risk ethnicity: Focus on South Asians #ASPC2023 Anand Rohatgi South Asians have excess coronary disease risk Cardiometabolic risk ‼️ 🔗 ahajournals.org/doi/full/10.11…

Patients presenting with MI but without standard modifiable cardiovascular risk factors may have increased risk of all-cause mortality and lower ️use of guideline directed medical therapy. #AHAJournals Zainali Chunawala Melissa Caughey PhD Dr. Deepak L. Bhatt Arman Qamar MD MPH ahajrnls.org/3OxIxhK

Impressive showing by UTSW Internal Medicine residents highlighting their research at AHA! UTSW Internal Medicine Chiefs @DinoKazi Anish Bhatt James MacNamara Denis Wakeham Nicholas Hendren Sandeep Das

Among patients hospitalized w/ ADHF, those w/ concurrent PAD have more prevalent 🫀 comorbidities and higher likelihood of 1-y ADHF readmission, irrespective of CKD status 🔗atherosclerosis-journal.com/article/S0021-… Zainali Chunawala Dr. Deepak L. Bhatt Arman Qamar MD MPH Muthu Vaduganathan Robert Mentz, MD Justin L. Grodin Melissa Caughey PhD

Integrating a more holistic approach in management of 👫 w/ concomitant HF, PAD and CKD may be an important strategy to improve the prognosis in this vulnerable population 🔗atherosclerosis-journal.com/article/S0021-… Zainali Chunawala Dr. Deepak L. Bhatt Arman Qamar MD MPH Muthu Vaduganathan Robert Mentz, MD Justin L. Grodin Melissa Caughey PhD

Check out our review on Non-Cardiac Biomarkers in Cardiogenic Shock: doi.org/10.1007/s11897… Maryjane Farr MD MSc, FACC FAST FHFSA FAHA UTSW Internal Medicine UTSW Heart #CardiogenicShock

Honored to be selected as a finalist for the Quest Diagnostics Early Career Investigator Award at #AHA2024! Deep gratitude to my mentors, ambarish and @KershawPatel, for their incredible mentorship and support. Excited to present at @AHAmeetings! @UTSWIMCHIEFS @UTSWHeart

Honored and grateful to be chosen as the recipient of George L. Bakris Scholarship! Looking forward to the #CMHC19thAnnual meeting.

#AHA24: How do cardiac biomarkers change after lifestyle intervention? In #JACC, Dr. Kershaw Patel, et al present results from the #LookAHEAD trial & find: 🔹Decreased hs-cTnT 🔹Transient NT-proBNP increase followed by long-term attenuation 📎: bit.ly/40OvWO2 #hscTnT